Literature DB >> 26756672

Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells.

Jaclyn M Sullivan1,2, Matthew C Havrda1,3, Arminja N Kettenbach1,4, Brenton R Paolella1,5, Zhonghua Zhang1,3, Scott A Gerber1,4,5, Mark A Israel1,3,5.   

Abstract

Inhibitor of DNA binding proteins (Id1-Id4) function to inhibit differentiation and promote proliferation of many different cell types. Among the Id family members, Id2 has been most extensively studied in the central nervous system (CNS). Id2 contributes to cultured neural precursor cell (NPC) proliferation as well as to the proliferation of CNS tumors such as glioblastoma that are likely to arise from NPC-like cells. We identified three phosphorylation sites near the N-terminus of Id2 in NPCs. To interrogate the importance of Id2 phosphorylation, Id2(-/-) NPCs were modified to express wild type (WT) Id2 or an Id2 mutant protein that could not be phosphorylated at the identified sites. We observed that NPCs expressing this mutant lacking phosphorylation near the N-terminus had higher steady-state levels of Id2 when compared to NPCs expressing WT Id2. This elevated level was the result of a longer half-life and reduced proteasome-mediated degradation. Moreover, NPCs expressing constitutively de-phosphorylated Id2 proliferated more rapidly than NPCs expressing WT Id2, a finding consistent with the well-characterized function of Id2 in driving proliferation. Observing that phosphorylation of Id2 modulates the degradation of this important cell-cycle regulator, we sought to identify a phosphatase that would stabilize Id2 enhancing its activity in NPCs and extended our analysis to include human glioblastoma-derived stem cells (GSCs). We found that expression of the phosphatase PP2A altered Id2 levels. Our findings suggest that inhibition of PP2A may be a novel strategy to regulate the proliferation of normal NPCs and malignant GSCs by decreasing Id2 levels. Stem Cells 2016;34:1321-1331.
© 2016 AlphaMed Press.

Entities:  

Keywords:  Cancer stem cells; Cellular proliferation; Glioma; Neoplastic stem cell biology; Neural stem cell; Progenitor cells; Tissue-specific stem cells; Transcription factors

Mesh:

Substances:

Year:  2016        PMID: 26756672      PMCID: PMC5024556          DOI: 10.1002/stem.2291

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  65 in total

1.  Degradation of Id proteins by the ubiquitin-proteasome pathway.

Authors:  M A Bounpheng; J J Dimas; S G Dodds; B A Christy
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  In vitro expansion of fetal neural progenitors as adherent cell lines.

Authors:  Steven M Pollard
Journal:  Methods Mol Biol       Date:  2013

4.  Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth.

Authors:  Anna Lasorella; Judith Stegmüller; Daniele Guardavaccaro; Guangchao Liu; Maria S Carro; Gerson Rothschild; Luis de la Torre-Ubieta; Michele Pagano; Azad Bonni; Antonio Iavarone
Journal:  Nature       Date:  2006-06-28       Impact factor: 49.962

5.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

6.  A genomewide survey of basic helix-loop-helix factors in Drosophila.

Authors:  A W Moore; S Barbel; L Y Jan; Y N Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation.

Authors:  Martin E Matsumura; David R Lobe; Coleen A McNamara
Journal:  J Biol Chem       Date:  2001-11-08       Impact factor: 5.157

8.  Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.

Authors:  A Lasorella; M Noseda; M Beyna; Y Yokota; A Iavarone
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

9.  The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.

Authors:  A Iavarone; P Garg; A Lasorella; J Hsu; M A Israel
Journal:  Genes Dev       Date:  1994-06-01       Impact factor: 11.361

10.  Determinants for Substrate Specificity of Protein Phosphatase 2A.

Authors:  Andrew M Slupe; Ronald A Merrill; Stefan Strack
Journal:  Enzyme Res       Date:  2011-07-02
View more
  9 in total

1.  Defining Trends in Global Gene Expression in Arabian Horses with Cerebellar Abiotrophy.

Authors:  E Y Scott; M C T Penedo; J D Murray; C J Finno
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

2.  KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.

Authors:  Lauren R Combs; Lauren McKenzie Spires; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

3.  Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.

Authors:  Woo Jin Bae; Bon Seok Koo; Sang Hyuk Lee; Jin Man Kim; Young Soo Rho; Jae Yol Lim; Jung Hwa Moon; Jae Hoon Cho; Young Chang Lim
Journal:  Br J Cancer       Date:  2017-11-02       Impact factor: 7.640

Review 4.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

5.  NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease.

Authors:  Katharine M von Herrmann; Lucas A Salas; Eileen M Martinez; Alison L Young; Joseph M Howard; Mary S Feldman; Brock C Christensen; Owen M Wilkins; Stephen L Lee; William F Hickey; Matthew C Havrda
Journal:  NPJ Parkinsons Dis       Date:  2018-08-15

Review 6.  Fostering open collaboration in drug development for paediatric brain tumours.

Authors:  Jong Fu Wong; Elizabeth J Brown; Eleanor Williams; Alex N Bullock
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

Review 7.  Shifting gears: Id3 enables recruitment of E proteins to new targets during T cell development and differentiation.

Authors:  Michele K Anderson
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

8.  Regulation of the Signal-Dependent E Protein HEBAlt Through a YYY Motif Is Required for Progression Through T Cell Development.

Authors:  Kogulan Yoganathan; Anqi Yan; Juliana Rocha; Ashton Trotman-Grant; Mahmood Mohtashami; Lisa Wells; Juan Carlos Zúñiga-Pflücker; Michele K Anderson
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

Review 9.  Id proteins: emerging roles in CNS disease and targets for modifying neural stemcell behavior.

Authors:  Yu-Hsuan Chu; Jia-di Lin; Suvra Nath; Christian Schachtrup
Journal:  Cell Tissue Res       Date:  2021-07-24       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.